Market Closed -
Japan Exchange
02:00:00 2024-04-24 am EDT
|
5-day change
|
1st Jan Change
|
1,405
JPY
|
0.00%
|
|
0.00%
|
-2.02%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
30,510
|
21,813
|
16,689
|
19,220
|
20,050
|
24,058
|
Enterprise Value (EV)
1 |
29,017
|
20,372
|
17,643
|
19,220
|
19,187
|
23,419
|
P/E ratio
|
15
x
|
35
x
|
106
x
|
14.8
x
|
7.64
x
|
22
x
|
Yield
|
2.62%
|
3.66%
|
4.79%
|
1.76%
|
4.5%
|
3.72%
|
Capitalization / Revenue
|
0.64
x
|
0.44
x
|
0.35
x
|
0.46
x
|
0.45
x
|
0.55
x
|
EV / Revenue
|
0.61
x
|
0.41
x
|
0.37
x
|
0.46
x
|
0.43
x
|
0.54
x
|
EV / EBITDA
|
6.76
x
|
6.84
x
|
5.93
x
|
8.36
x
|
8.15
x
|
9.1
x
|
EV / FCF
|
-863
x
|
8.84
x
|
-8.08
x
|
11.9
x
|
157
x
|
-1,368
x
|
FCF Yield
|
-0.12%
|
11.3%
|
-12.4%
|
8.4%
|
0.64%
|
-0.07%
|
Price to Book
|
0.68
x
|
0.5
x
|
0.39
x
|
0.43
x
|
0.42
x
|
0.49
x
|
Nbr of stocks (in thousands)
|
23,505
|
23,505
|
23,505
|
22,505
|
22,553
|
22,379
|
Reference price
2 |
1,298
|
928.0
|
710.0
|
854.0
|
889.0
|
1,075
|
Announcement Date
|
6/21/18
|
6/20/19
|
6/23/20
|
6/18/21
|
6/24/22
|
6/23/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
47,942
|
49,638
|
48,217
|
42,205
|
44,456
|
43,667
|
EBITDA
1 |
4,295
|
2,980
|
2,976
|
2,298
|
2,353
|
2,573
|
EBIT
1 |
1,911
|
369
|
547
|
200
|
220
|
318
|
Operating Margin
|
3.99%
|
0.74%
|
1.13%
|
0.47%
|
0.49%
|
0.73%
|
Earnings before Tax (EBT)
1 |
2,740
|
980
|
570
|
1,629
|
3,065
|
1,854
|
Net income
1 |
2,047
|
627
|
158
|
1,323
|
2,651
|
1,107
|
Net margin
|
4.27%
|
1.26%
|
0.33%
|
3.13%
|
5.96%
|
2.54%
|
EPS
2 |
86.71
|
26.55
|
6.690
|
57.86
|
116.4
|
48.82
|
Free Cash Flow
1 |
-33.62
|
2,305
|
-2,183
|
1,615
|
122.1
|
-17.12
|
FCF margin
|
-0.07%
|
4.64%
|
-4.53%
|
3.83%
|
0.27%
|
-0.04%
|
FCF Conversion (EBITDA)
|
-
|
77.36%
|
-
|
70.28%
|
5.19%
|
-
|
FCF Conversion (Net income)
|
-
|
367.68%
|
-
|
122.08%
|
4.61%
|
-
|
Dividend per Share
2 |
34.00
|
34.00
|
34.00
|
15.00
|
40.00
|
40.00
|
Announcement Date
|
6/21/18
|
6/20/19
|
6/23/20
|
6/18/21
|
6/24/22
|
6/23/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
954
|
-
|
-
|
-
|
Net Cash position
1 |
1,493
|
1,441
|
-
|
-
|
863
|
639
|
Leverage (Debt/EBITDA)
|
-
|
-
|
0.3206
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-33.6
|
2,305
|
-2,183
|
1,615
|
122
|
-17.1
|
ROE (net income / shareholders' equity)
|
4.74%
|
1.42%
|
0.51%
|
3.05%
|
5.59%
|
2.42%
|
ROA (Net income/ Total Assets)
|
1.88%
|
0.35%
|
0.51%
|
0.18%
|
0.2%
|
0.29%
|
Assets
1 |
108,842
|
180,640
|
30,932
|
716,685
|
1,328,156
|
384,776
|
Book Value Per Share
2 |
1,919
|
1,872
|
1,812
|
1,973
|
2,128
|
2,178
|
Cash Flow per Share
2 |
336.0
|
339.0
|
406.0
|
416.0
|
404.0
|
289.0
|
Capex
1 |
3,038
|
1,406
|
3,785
|
1,732
|
2,661
|
1,288
|
Capex / Sales
|
6.34%
|
2.83%
|
7.85%
|
4.1%
|
5.99%
|
2.95%
|
Announcement Date
|
6/21/18
|
6/20/19
|
6/23/20
|
6/18/21
|
6/24/22
|
6/23/23
|
|
1st Jan change
|
Capi.
|
---|
| -2.02% | 201M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|